- Seclusion and restraint for people with serious mental illnesses
- Second‐generation antidepressants for treatment of seasonal affective disorder
- Second-generation antipsychotics for anxiety disorders
- Second-generation antipsychotics for major depressive disorder and dysthymia
- Second-generation antipsychotics for obsessive compulsive disorder
- Sedatives for opioid withdrawal in newborn infants
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
- Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
- Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
- Selective serotonin re‐uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
- Selective serotonin reuptake inhibitors for premenstrual syndrome
- Selegiline for Alzheimer's disease
- Self-help and guided self-help for eating disorders
- Sensory environment on health-related outcomes of hospital patients
- Sertindole for schizophrenia
- Sertindole versus other atypical antipsychotics for schizophrenia
- Sertraline versus other antidepressive agents for depression
- Shared decision‐making interventions for people with mental health conditions
- Short‐term psychodynamic psychotherapies for common mental disorders
- Silver acetate for smoking cessation
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.
